Search
NEWS

Current approved therapeutic strategies for IPF and LC treatment

By A Mystery Man Writer

Current approved therapeutic strategies for IPF and LC treatment

Up-regulated SPP1 increases the risk from IPF to lung cancer via activating the pro-tumor macrophages - Computational and Structural Biotechnology Journal

Current approved therapeutic strategies for IPF and LC treatment

Idiopathic Pulmonary Fibrosis (IPF) Workup: Laboratory Studies, Imaging Studies, Other Tests

Current approved therapeutic strategies for IPF and LC treatment

Filippo GOZZI, Medical Doctor

Current approved therapeutic strategies for IPF and LC treatment

Massimo DOMINICI Università degli Studi di Modena e Reggio

Current approved therapeutic strategies for IPF and LC treatment

Frontiers Mitochondria in Focus: From Function to Therapeutic Strategies in Chronic Lung Diseases

Current approved therapeutic strategies for IPF and LC treatment

IJMS, Free Full-Text

Current approved therapeutic strategies for IPF and LC treatment

Comparison of survival probabilities of IPF patients with and without

Current approved therapeutic strategies for IPF and LC treatment

Stefania CERRI, Assistant Professor, MD, PhD

Current approved therapeutic strategies for IPF and LC treatment

Beatrice ARAMINI, MD PhD